全文获取类型
收费全文 | 16433篇 |
免费 | 766篇 |
国内免费 | 128篇 |
专业分类
耳鼻咽喉 | 59篇 |
儿科学 | 222篇 |
妇产科学 | 243篇 |
基础医学 | 1830篇 |
口腔科学 | 39篇 |
临床医学 | 2020篇 |
内科学 | 1236篇 |
皮肤病学 | 82篇 |
神经病学 | 5019篇 |
特种医学 | 92篇 |
外科学 | 391篇 |
综合类 | 2190篇 |
预防医学 | 1387篇 |
眼科学 | 24篇 |
药学 | 1595篇 |
4篇 | |
中国医学 | 760篇 |
肿瘤学 | 134篇 |
出版年
2024年 | 20篇 |
2023年 | 210篇 |
2022年 | 428篇 |
2021年 | 655篇 |
2020年 | 619篇 |
2019年 | 467篇 |
2018年 | 497篇 |
2017年 | 589篇 |
2016年 | 580篇 |
2015年 | 577篇 |
2014年 | 1395篇 |
2013年 | 1433篇 |
2012年 | 1100篇 |
2011年 | 1468篇 |
2010年 | 987篇 |
2009年 | 974篇 |
2008年 | 940篇 |
2007年 | 816篇 |
2006年 | 630篇 |
2005年 | 490篇 |
2004年 | 418篇 |
2003年 | 359篇 |
2002年 | 273篇 |
2001年 | 181篇 |
2000年 | 142篇 |
1999年 | 109篇 |
1998年 | 90篇 |
1997年 | 95篇 |
1996年 | 58篇 |
1995年 | 62篇 |
1994年 | 48篇 |
1993年 | 41篇 |
1992年 | 35篇 |
1991年 | 34篇 |
1990年 | 30篇 |
1989年 | 21篇 |
1988年 | 37篇 |
1987年 | 30篇 |
1986年 | 22篇 |
1985年 | 72篇 |
1984年 | 53篇 |
1983年 | 25篇 |
1982年 | 30篇 |
1981年 | 29篇 |
1980年 | 16篇 |
1979年 | 27篇 |
1978年 | 22篇 |
1977年 | 14篇 |
1975年 | 13篇 |
1974年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 724 毫秒
91.
负性生活事件对抑郁症患者血清细胞因子水平的影响 总被引:9,自引:0,他引:9
目的 探讨负性生活事件对抑郁症患者血清细胞因子水平的影响。方法 采用酶联免疫吸附法 (EL SIA)对有负性生活事件诱因的抑郁症患者 2 3例、无诱因的抑郁症患者 2 9例和 2 9名正常人的血清白介素 2 (IL 2 )、可溶性白介素 2受体 (sIL 2R)、白介素 10 (IL 10 )和白介素 12 (IL 12 )水平进行检测。结果 3组间IL 2、sIL 2R及IL 12水平存在显著性差异 ,而IL 10则 3组间无显著性差异 ,有负性生活事件诱因组IL 2及sIL 2R水平明显低于无诱因组和对照组 (P <0 0 1) ;有诱因组其负性生活事件对患者心理活动影响的严重程度与IL 2和sIL 2R水平呈负相关(P <0 0 5 )。结论 负性生活事件对抑郁症患者的细胞免疫激活系统有抑制作用 ,IL 2可能是起主要的中介作用。 相似文献
92.
目的 评价氟西汀治疗高血压伴抑郁症状的效果。方法 70例原发高血压病伴抑郁症状的患者,分成治疗组和对照组,两组均用降压药物治疗,治疗组加用氟西汀,两周后观察疗效。结果 治疗组和对照组的有效率分别为78.9%和56.3%。两组比较差异显著。结论 氟西汀治疗高血压伴抑郁症状有显著疗效。 相似文献
93.
目的探讨认知疗法在老年抑郁症治疗中的作用。方法将70例老年抑郁症患者随机分为两组,A组为认知疗法合并文拉法新缓释剂治疗组;B组为单纯用文拉法新缓释剂治疗组。于治疗前后分别用汉密顿抑郁量表(HAMD)、汉密顿焦虑量表(HAMA)、疗效总评量表(CGI-GI)评定疗效,半年后随访。结果A、B组的HAMD评分于治疗2周末呈非常显著下降(P<0.01),HAMA于治疗4周末出现这种变化(P<0.01)。A组治疗8周末的3个量表评分均显著低于B组(P<0.01),A组有效率达87.5%,高于B组的60.61%(P<0.05),半年复发率(6.25%)也显著低于B组(30.3%)。结论认知疗法是适合老年抑郁症的心理治疗方法。 相似文献
94.
Depression has received increasing attention as a significant public health issue over the past ten years, both in Canada and elsewhere in the industrialized west. During the same period, many of the social and economic policies adopted by governments in these jurisdictions have reflected neoliberal goals and orientations. The purpose of this article is to explore the points of contact between these two features of contemporary social and political life in the industrialized west, using the Canadian province of British Columbia as an empirical site. My analysis draws on the Foucauldian literature on governmentality in presenting a close reading of provincial government documents concerned with depression and mental health literacy that have been produced since the election of the Liberal Party to office in British Columbia in 2001. This analysis identifies discourses of “responsibilization” circulating in these documents, within which individuals, families, communities and workplaces – rather than publicly-funded services – appear as key resources in responding to experiences of mental distress. It also points to a number of strategies visible in the documents that work to align the interests of individuals and their practitioners in pursuing particular approaches to treatment with a governing interest in reducing public spending on services and supports. The article concludes by identifying a number of resistive discourses and proposing further research in a range of empirical contexts within which they may be evident. 相似文献
95.
C. Foulon J.D. Guelfi A. Kipman J. Ads L. Romo K. Houdeyer S. Marquez M.C. Mouren F. Rouillon P. Gorwood 《European psychiatry》2007,22(8):513-519
OBJECTIVE: Anorexia nervosa has the highest suicide mortality ratio of psychiatric disorders, suicide being associated with many factors. We assessed the first lifetime occurrence of these factors taking into account their possible overlap. METHOD: Three hundred and four in- and out-patients with anorexia nervosa (DSM-IV) were systematically recruited in three hospitals of Paris suburbs, between December 1999 and January 2003. Patients were assessed by a face-to-face interview (DIGS). Current eating disorder dimensions were measured, and patients interviewed by a trained clinician to assess minimal BMI and, retrospectively, the age at which anorexia nervosa, major depressive disorder, anxiety disorders and switch to bingeing/purging type occurred for the first time, if applicable. RESULTS: Major depressive disorder (p<0.001) and subtype switch from the restrictive to the bingeing/purging type (p<0.001) were the two factors significantly more frequently occurring before suicidal attempts, and remained involved when a multivariate analysis is performed, whether syndromic or dimensional measures are being used. Taking into account lifetime occurrence with a survival analysis, the switch to bingeing/purging type of anorexia appears as a major predictive factor, with a large increase of the frequency of suicidal attempts (OR=15) when compared to patients with neither major depressive disorder nor bingeing/purging type. CONCLUSIONS: Bingeing/purging type of anorexia nervosa is largely associated with suicidal attempts, and may deserve specific attention. If confirmed on a prospectively designed study, these results would argue for early detection and/or more intensive and specific therapeutic intervention on this aspect of bingeing and purging behaviors. 相似文献
96.
电针对抑郁大鼠5-羟色胺和乙酰胆碱酯酶在海马表达的影响 总被引:2,自引:1,他引:1
目的:探究电针治疗抑郁症的作用机制。方法:将健康Wistar大鼠随机分为正常组10只,模型组和电针组各11只,慢性应激法21 d造模。电针组选穴"百会""三阴交",以频率2 Hz、电流强度1 mA,行电针治疗20 min,每日1次。14 d后处死动物,通过免疫组化法测定5-羟色胺(5-HT)和乙酰胆碱酯酶(AChE)在海马区的积分吸光度(IOD)值。结果:造模后造模组与正常组比较,水平、垂直运动次数和糖水消耗量均减少(P<0.001)。模型组与正常组相比,5-HT和AChE的IOD值减小(P<0.05);电针组与模型组相比,两指标的IOD值明显升高(P<0.05)。结论:抑郁大鼠海马5-HT和AChE活性降低,电针可明显提高大鼠海马中5-HT、AChE的表达,从而发挥其抗抑郁作用。 相似文献
97.
Dr. S. K. Gupta J. C. Ritchie E. H. Ellinwood K. Wiedemann F. Holsboer 《European journal of clinical pharmacology》1992,43(1):51-55
Summary Changes in time course effected by cortisol suppression and the relationship of these changes to the plasma dexamethasone concentration of suppressor and non-suppressor patients are described in this report on a combined pharmacokinetic-pharmacodynamic model.Thirteen depressed patients (8 suppressors and 5 non-suppressors) received an intravenous dose (1.5 mg) of dexamethasone. The drug-induced effect changes are found to lag behind, in time, the plasma drug level changes. To accurately relate the temporal relationship of effect changes to plasma dexamethasone levels, a pharmacodynamic model (sigmoid-Emax) was combined with a pharmacokinetic model that incorporated an effect compartment. The magnitude of the time-lag was quantified by the half-time of equilibration between concentrations in the hypothetical effect compartment and the plasma dexamethasone levels (t&frac;keo).The t&frac;keo of the nonsuppressing group was about 50 of that of the suppressing group, indicating that for a given plasma level the onset and termination of effect for the nonsuppressing group is about two times more rapid than for the suppressing group. Moreover, the model can estimate the effect-site concentration that causes one-half of the maximal predicted effect (EC50), a measure of an individual's sensitivity to dexamethasone. The receptor sensitivity (as determined from the EC50 ratio) of the suppressing group was about twice that of the nonsuppressing group. 相似文献
98.
Karl A. Greene M.D. Ph.D. Curtis A. Dickman M.D. Kris A. Smith M.D. Eugene J. Kinder M.D. Joseph M. Zabramski M.D. 《Surgical neurology》1993,40(6):499-503
Reports of intracranial self-multilation by psychotic individuals are associated with severe mental disorders, criminality, or both. We describe a psychotically depressed male who drove a ballpoint pen through his right medial canthus and into his intracranial compartment. The patient developed a cavernous sinus syndrome and a traumatic dissection of the cavernous portion of the carotid artery. The pen was removed intraoperatively. Postoperatively, the patient was placed on a course of broad-spectrum antibiotics, antidepressants, and antipsychotic medications, and he has received long-term psychiatric follow-up. The literature related to these unusual cases is reviewed, and relevant surgical, medical, and psychiatric aspects of treatment are discussed. 相似文献
99.
J. De Vry 《Psychopharmacology》1995,121(1):1-26
During the last decade, serotonin (5-HT)1A receptors have been a major target for neurobiological research and drug development. 5-HT1A receptors have been cloned and a variety of selective agonists, such as the aminotetraline 8-OH-DPAT and the pyrimidinylpiperazine ipsapirone, have become available. Demonstrations of apparent intrinsic activity of these ligands at 5-HT1A receptors, however, depend highly on the particular assay system. This may be due to the possible existence of receptor subtypes and to assay (or brain region)-dependent differences in receptor reserve and the nature of receptor-effector coupling. Nevertheless, the apparent intrinsic activity of 8-OH-DPAT seems to be higher (although possibly not yet maximal) than that of the pyrimidinylpiperazines. In the brain, 5-HT1A receptors are located presynaptically as somatodendritic receptors on 5-HT neurons and postsynaptically in particular limbic and cortical regions. Although it is generally accepted that presynaptic 5-HT1A receptors control 5-HT neuronal activity, recent evidence suggests an additional role of postsynaptic 5-HT1A receptors in cortex as part of a negative feedback loop. Anxiolytic and antidepressive properties of selective 5-HT1A receptor agonists have now been confirmed by clinical studies. Although it is well established that the latter properties depend on theagonistic activity of these compounds, theoptimal level of intrinsic activity is still a matter of debate and may be dependent on the clinical indication. Such compounds may also have antiaggressive effects, and possibly anticraving effects (manifested by their alcohol intake-reducing effects in dependent animals), but the specificity of these so-called anti-impulsivity effects is still controversial and not yet tested clinically. Anticataleptic, antiemetic and neuroprotective properties have been demonstrated in different species. Behavioral studies on the mechanisms underlying the anxiolytic and antidepressive effects have examined the relative contribution of pre-and postsynaptic 5-HT1A receptors by means of local cerebral application and lesion techniques. Most evidence points towards a critical involvement of presynaptic receptors in the anxiolytic effects of 5-HT1A receptor agonists (although a possible contribution of postsynaptic receptors cannot be excluded). With regard to the antidepressive properties, a case can be made for the reverse; i.e., a strong involvement of postsynaptic receptors and a questionable contribution of presynaptic receptors. However, as the therapeutic effects of those 5-HT1A receptor (partial) agonists which have been tested clinically require repeated administration, attention has been directed increasingly towards chronic studies. These studies have shown that a number of electrophysiological, biochemical, behavioral and endocrinological 5-HT1A receptor-related events adapt differentially to repeated or sustained administration. Thus, several hypotheses accounting for the delayed onset of action have been advanced. Among these, time-dependent downregulation /desensitization of eitherpre- orpostsynaptic 5-HT1A receptors, or cortical 5-HT2 receptors have received much attention. However, these hypotheses have their weaknesses, and it is argued thatfunctional sensitization of particular postsynaptic 5-HT1A receptor-mediated events remains a valuable alternate hypothesis. Basic research on the role of 5-HT1A receptors in psychopathology and in the therapeutic effects of clinically effective therapeutics, as well as on the mechanism of action of 5-HT1A receptor ligands, will enable rational design of ligands with particular profiles of intrinsic activity at different 5-HT1A receptor populations, and may contribute to a more efficient treatment of a multiplicity of brain disorders. 相似文献
100.
曲唑酮治疗抑郁症的疗效观察 总被引:1,自引:0,他引:1
目的:观察曲唑酮治疗抑郁症的疗效。方法:对31例抑郁症患者给予每日50~250mg曲唑酮治疗,不合用其它精神药物,并用汉密尔顿抑郁量表(HAMD),不良反应症状量表(TESS)进行治疗前后对照。结果:痊愈20例,显著进步6例,进步2例,无效3例,总有效率90.3%。结论:曲唑酮是一种强效而安全的抗抑郁药。 相似文献